Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 27 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

5%

1 of 19 completed trials have results

Key Signals

5 recruiting1 with results

Enrollment reporting

Analytics

N/A
9(56.3%)
Phase 2
4(25.0%)
Phase 2/3
1(6.3%)
Phase 1
1(6.3%)
Phase 3
1(6.3%)
16Total
N/A(9)
Phase 2(4)
Phase 2/3(1)
Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials
NCT05989802Not ApplicableRecruiting

Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)

Role: collaborator

NCT04303104Not ApplicableCompleted

Xpert Active Case-finding Trial 3 (XACT-3)

Role: collaborator

NCT06593080Not ApplicableRecruiting

The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis

Role: collaborator

NCT06064591Completed

Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX

Role: collaborator

NCT05002322Not ApplicableCompleted

Expanding Health Systems Research to Optimize Hypertension Care Cascade in HIV-Infected Individuals in Mozambique

Role: collaborator

NCT03313128Completed

SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance

Role: collaborator

NCT06747507Phase 3Recruiting

Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance

Role: collaborator

NCT06762054Recruiting

Investigating the Optimal Management of Dolutegravir Resistance

Role: collaborator

NCT05686356Phase 2/3Active Not Recruiting

A Pan-TB Regimen Targeting Host and Microbe

Role: collaborator

NCT06970600Not ApplicableCompleted

Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under 12 Years at Four Sentinel Sites in Mozambique

Role: collaborator

NCT04568954Not ApplicableCompleted

TB-CAPT CORE Truenat Trial

Role: collaborator

NCT04568967Not ApplicableCompleted

TB-CAPT EXULTANT - HIV

Role: collaborator

NCT04442165Completed

Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique

Role: collaborator

NCT04066881Phase 2Completed

A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP

Role: collaborator

NCT04032522Completed

Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID- Long Term Impact on inFant hEalth (LIFE)

Role: collaborator

NCT06326294Not ApplicableRecruiting

Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique

Role: lead

NCT05022407Completed

COVID-19 and HIV in Health Workers in Mozambique

Role: lead

NCT04027036Phase 2Completed

Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally

Role: lead

NCT05228639Completed

COVID-19 Surveillance in Rural Mozambique for Prompt and Effective Response

Role: collaborator

NCT03734172Completed

Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB)

Role: collaborator